Gliclazide: Enhancing Diabetes Management
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Admira MR Tablet: Empowering Diabetes Control
Avoid consuming alcohol while taking Admira MR Tablet, as it could worsen your condition.
It is generally not advised to use Admira MR Tablet during pregnancy. Consult your doctor before taking it if you are pregnant.
Admira MR Tablet is generally not recommended for use in breastfeeding women. Consult your doctor before taking it if you are breastfeeding.
If you experience dizziness or blurred vision after taking Admira MR Tablet, avoid driving or operating machinery.
Admira MR Tablet is not recommended for use in patients with severe kidney disease. If you have decreased kidney function, use it with caution and consult your doctor.
Admira MR Tablet is not recommended for use in patients with severe liver disease. If you have decreased liver function, use it with caution and consult your doctor.
Admira MR Tablet works by increasing the release of insulin from your pancreas (a part of your digestive system that produces insulin and other vital enzymes). Thus it lowers your blood sugar levels.
Admira MR Tablet is used to treat maturity-onset diabetes, and diabetes with or without obesity in adults when diet, exercise, weight loss, or insulin therapy fail to provide adequate results.
Gliclazide, a second-generation sulfonylurea, holds hypoglycemic and potential hematological impacts. It curbs the liver's glucose production, concurrently spurring insulin secretion from pancreatic β-cells. This is achieved by enhancing Ca+2 transportation across the β-cell membranes.
Certain medications can interact with Gliclazide, affecting its hypoglycemic (blood sugar-lowering) effects:
Enhancing Hypoglycemic Effects:
Decreasing Hypoglycemic Effects:
Juvenile-Onset (Type-1) Diabetes: Gliclazide is not suitable for individuals with type-1 diabetes, which is characterized by the inability of the pancreas to produce insulin.
Diabetes Associated with Ketosis: Gliclazide is not recommended for diabetes patients experiencing ketosis, a condition where the body burns fat for energy due to insufficient insulin.
Diabetic Patients Undergoing Surgery, Severe Injury, or Infection: Gliclazide should be avoided in diabetic patients who are undergoing surgery, have experienced a severe injury, or are dealing with infections, as their medical conditions may affect the use of the medication.
Hypersensitivity to Sulfonylurea Group: If a patient has a known hypersensitivity or allergy to drugs in the sulfonylurea group, Gliclazide should not be used.
Pregnancy and Breastfeeding: Gliclazide is not recommended for pregnant or breastfeeding women due to potential risks to the fetus or infant.
Hepatic Insufficiency: Gliclazide should be avoided in patients with severe liver insufficiency.
Pregnant women should avoid using gliclazide. It should not be used by a woman who is breastfeeding.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.